文献速递青光眼

用眼内遥测传感器测量局部β肾上腺素受体阻断剂及其固定组合的昼夜眼压效应

Nyctohemeral effects of topical beta-adrenoceptor blocking agents measured with an intraocular telemetry sensor.
PubMed 文献 · Br J Ophthalmol · 2025-04-22

这项前瞻性临床试验纳入22例已植入巩膜沟眼压传感器的原发性开角型青光眼患者,分析β受体阻断剂(BB)、BB与碳酸酐酶抑制剂固定组合(BB-CAI)及BB与前列腺素类似物组合(BB-PGA)对昼夜眼压的影响。共纳入10只眼的50 920次眼压测量(4084天),BB-PGA组24小时平均眼压17.3±1.1 mm Hg显著低于BB组18.8±1.1 mm Hg(p<0.001);BB-PGA组和BB-CAI组24小时眼压标准差均显著低于BB组,BB-PGA组24小时眼压四分位距显著低于BB组和BB-CAI组。持续眼压监测显示BB-PGA组合降低24小时眼压波动的作用比BB-CAI和单用BB更明显。

要点

  • BB-PGA组24小时平均眼压17.3±1.1 mm Hg,显著低于BB组18.8±1.1 mm Hg(p<0.001)。
  • BB-PGA组和BB-CAI组24小时眼压标准差均显著低于BB组(p<0.05)。
  • BB-PGA组24小时眼压四分位距显著低于BB组和BB-CAI组。

核心结论

  • 持续眼压监测显示BB-PGA组合降低24小时眼压波动的作用比BB-CAI和单用BB更明显。

研究设计与样本

  • 前瞻性临床试验纳入22例既往植入巩膜沟眼压传感器(eyemate)的原发性开角型青光眼患者,分析BB、BB-CAI和BB-PGA三类药物。

主要发现

  • 患者平均年龄67.8±6.8岁,女性占36.4%;共纳入10只眼的50 920次眼压测量,覆盖4084天。
  • BB-PGA组24小时平均眼压17.3±1.1 mm Hg显著低于BB组18.8±1.1 mm Hg(p<0.001);BB-CAI组18.4±1.1 mm Hg与其他两类药物相似(p>0.05)。
  • BB-PGA组24小时眼压标准差1.9±0.2 mm Hg和BB-CAI组2.0±0.2 mm Hg均显著低于BB组2.4±0.2 mm Hg(p<0.05)。
  • BB-PGA组24小时眼压四分位距2.3±0.4 mm Hg显著低于BB组3.8±0.4 mm Hg和BB-CAI组3.2±0.4 mm Hg。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate nyctohemeral effects of topical beta-adrenoceptor blocking agents and their fixed combinations on intraocular pressure (IOP) in patients with primary open-angle glaucoma implanted with an ocular telemetry sensor. METHODS: 22 patients who had previously been implanted with a sulcus-based IOP sensor (eyemate) were included in this prospective clinical trial. Three classes of medications were analysed: beta-blockers (BB), fixed combination of BB and carbonic anhydrase inhibitors (BB-CAI), and combinations of BB and prostaglandin analogues (BB-PGAs). SD and IQR of IOP were calculated and used as surrogates of nyctohemeral IOP variation. RESULTS: The mean (±SD) age of patients was 67.8±6.8 years (36.4% female). A total of 50 920 IOP measurements over 4084 days from 10 eyes were included. The mean 24-hour IOP (±SE) with BB-PGA (17.3±1.1 mm Hg) was significantly (p<0.001) less than that with BB (18.8±1.1 mm Hg). Mean 24-hour IOP with BB-CAI (18.4±1.1 mm Hg) was similar (p>0.05) to that with the other two medications. Mean 24-hour SD of IOP with BB-PGA (1.9±0 .2 mm Hg) and BB-CAI (2.0±0.2 mm Hg) were significantly (p<0.05) less than that with BB (2.4±0.2 mm Hg). Mean 24-hour IQR of IOP with BB-PGA (2.3±0.4 mm Hg) was significantly less than that with both BB (3.8±0.4 mm Hg) and BB-CAI (3.2±0.4 mm Hg). CONCLUSION: Continual IOP monitoring shows that combinations of BB-PGAs have more pronounced effects on lowering 24-hour IOP fluctuations than BB-CAIs and BBs alone. TRIAL REGISTRATION NUMBER: NCT03651336.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Mansouri K, Rao HL, Weinreb RN, et al. Nyctohemeral effects of topical beta-adrenoceptor blocking agents measured with an intraocular telemetry sensor. Br J Ophthalmol. 2025. PMID: 39510809. doi:10.1136/bjo-2023-324760

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。